Collegese

Welcome to Collegese! Sign in →

Collegese

    Search colleges and courses

    Search and navigate to colleges and courses

    Start your journey

    Ready to find your dream college?

    Join thousands of students making smarter education decisions.

    Watch How It WorksGet Started

    Discover

    Browse & filter colleges

    Compare

    Side-by-side analysis

    Explore

    Detailed course info

    Collegese

    India's education marketplace helping students discover the right colleges, compare courses, and build careers they deserve.

    © 2026 Collegese. All rights reserved. A product of Nxthub Consulting Pvt. Ltd.

    Apply

    Scholarships & exams

    support@collegese.com
    +91 88943 57155
    Pune, Maharashtra, India

    Duration

    4 Years

    Drug Regulatory Affairs

    Ramanand Institute Of Pharmacy And Management Haridwar
    Duration
    4 Years
    Drug Regulatory Affairs UG OFFLINE

    Duration

    4 Years

    Drug Regulatory Affairs

    Ramanand Institute Of Pharmacy And Management Haridwar
    Duration
    Apply

    Fees

    ₹8,00,000

    Placement

    94.5%

    Avg Package

    ₹5,60,000

    Highest Package

    ₹8,50,000

    OverviewAdmissionsCurriculumFeesPlacements
    4 Years
    Drug Regulatory Affairs
    UG
    OFFLINE

    Fees

    ₹8,00,000

    Placement

    94.5%

    Avg Package

    ₹5,60,000

    Highest Package

    ₹8,50,000

    Seats

    120

    Students

    120

    ApplyCollege

    Seats

    120

    Students

    120

    Curriculum

    Comprehensive Curriculum Overview for Drug Regulatory Affairs Program

    The curriculum for the Drug Regulatory Affairs program at Ramanand Institute Of Pharmacy And Management Haridwar is structured to provide students with a holistic understanding of regulatory processes, compliance mechanisms, and ethical frameworks governing pharmaceutical products. The program spans eight semesters and integrates foundational sciences with specialized regulatory knowledge through a carefully curated sequence of core courses, departmental electives, science electives, and laboratory practicals.

    Course Structure Across Eight Semesters
    SEMESTERCOURSE CODECOURSE TITLECREDIT STRUCTURE (L-T-P-C)PREREQUISITES
    Semester IPH101Chemistry for Pharmacy I3-0-2-4-
    PH102Biology for Pharmacy I3-0-2-4-
    PH103Physics for Pharmacy I3-0-2-4-
    PH104Mathematics I3-0-2-4-
    PH105English Communication Skills2-0-0-2-
    PH106Introduction to Pharmaceutical Sciences3-0-2-4-
    PH107Computer Applications in Pharmacy2-0-2-3-
    PH108Pharmaceutical Ethics and Professionalism2-0-0-2-
    PH109Introduction to Regulatory Affairs2-0-0-2-
    PH110Pharmaceutical Chemistry I3-0-2-4-
    PH111Pharmacology I3-0-2-4-
    PH112Toxicology I3-0-2-4-
    PH113Pharmaceutical Calculations2-0-0-2-
    PH114Chemistry Lab I0-0-6-2-
    PH115Biology Lab I0-0-6-2-
    Semester IIPH201Chemistry for Pharmacy II3-0-2-4PH101
    PH202Biology for Pharmacy II3-0-2-4PH102
    PH203Physics for Pharmacy II3-0-2-4PH103
    PH204Mathematics II3-0-2-4PH104
    PH205Organic Chemistry I3-0-2-4-
    PH206Pharmacology II3-0-2-4PH111
    PH207Toxicology II3-0-2-4PH112
    PH208Pharmaceutical Analysis I3-0-2-4-
    PH209Pharmaceutical Chemistry II3-0-2-4PH110
    PH210Medicinal Chemistry I3-0-2-4-
    PH211Pharmacognosy I3-0-2-4-
    PH212Pharmaceutical Technology I3-0-2-4-
    PH213Pharmacology Lab I0-0-6-2PH206
    PH214Chemistry Lab II0-0-6-2PH201
    PH215Biology Lab II0-0-6-2PH202
    Semester IIIPH301Pharmacology III3-0-2-4PH206
    PH302Pharmaceutical Chemistry III3-0-2-4PH209
    PH303Medicinal Chemistry II3-0-2-4PH210
    PH304Pharmacognosy II3-0-2-4PH211
    PH305Pharmaceutical Technology II3-0-2-4PH212
    PH306Pharmaceutical Analysis II3-0-2-4PH208
    PH307Pharmacology Lab II0-0-6-2PH301
    PH308Chemistry Lab III0-0-6-2PH214
    PH309Biology Lab III0-0-6-2PH215
    PH310Pharmaceutical Chemistry Lab I0-0-6-2PH209
    PH311Pharmacognosy Lab I0-0-6-2PH304
    PH312Medicinal Chemistry Lab I0-0-6-2PH303
    PH313Pharmaceutical Technology Lab I0-0-6-2PH305
    PH314Regulatory Affairs I2-0-0-2-
    PH315Pharmacovigilance Fundamentals2-0-0-2-
    Semester IVPH401Pharmacology IV3-0-2-4PH301
    PH402Pharmaceutical Chemistry IV3-0-2-4PH302
    PH403Medicinal Chemistry III3-0-2-4PH303
    PH404Pharmacognosy III3-0-2-4PH304
    PH405Pharmaceutical Technology III3-0-2-4PH305
    PH406Pharmaceutical Analysis III3-0-2-4PH306
    PH407Regulatory Affairs II2-0-0-2PH314
    PH408Good Manufacturing Practices (GMP)2-0-0-2-
    PH409Good Clinical Practices (GCP)2-0-0-2-
    PH410Pharmacovigilance Advanced2-0-0-2PH315
    PH411Regulatory Writing and Documentation2-0-0-2-
    PH412Quality Assurance Systems2-0-0-2-
    PH413Pharmacology Lab III0-0-6-2PH401
    PH414Chemistry Lab IV0-0-6-2PH308
    PH415Biology Lab IV0-0-6-2PH309
    Semester VPH501Regulatory Affairs III2-0-0-2PH407
    PH502Biologics and Advanced Therapies Regulation2-0-0-2-
    PH503Clinical Research Regulation2-0-0-2-
    PH504Global Regulatory Strategy2-0-0-2-
    PH505Post-Market Surveillance Regulation2-0-0-2-
    PH506Regulatory Affairs in Emerging Technologies2-0-0-2-
    PH507Pharmaceutical Quality Assurance Regulation2-0-0-2-
    PH508Pediatric Drug Development Regulation2-0-0-2-
    PH509Regulatory Compliance Audits2-0-0-2-
    PH510International Drug Approval Process2-0-0-2-
    PH511Regulatory Risk Management2-0-0-2-
    PH512Pharmacovigilance Systems2-0-0-2PH410
    PH513Regulatory Affairs Case Studies2-0-0-2-
    PH514Regulatory Affairs Workshop0-0-6-2-
    PH515Mini Project I0-0-6-2-
    Semester VIPH601Regulatory Affairs IV2-0-0-2PH501
    PH602Advanced Clinical Trial Design2-0-0-2-
    PH603Regulatory Affairs in Digital Health2-0-0-2-
    PH604Regulatory Affairs for Orphan Drugs2-0-0-2-
    PH605Regulatory Affairs in Vaccine Development2-0-0-2-
    PH606International Harmonization Efforts2-0-0-2-
    PH607Regulatory Ethics and Governance2-0-0-2-
    PH608Pharmacovigilance Data Management2-0-0-2PH512
    PH609Regulatory Affairs for Personalized Medicine2-0-0-2-
    PH610Global Regulatory Compliance Trends2-0-0-2-
    PH611Regulatory Affairs in Emerging Markets2-0-0-2-
    PH612Regulatory Affairs Capstone Project0-0-6-2-
    PH613Mini Project II0-0-6-2PH515
    PH614Regulatory Affairs Internship0-0-12-2-
    PH615Research Methodology2-0-0-2-
    Semester VIIPH701Regulatory Affairs V2-0-0-2PH601
    PH702Regulatory Affairs in Public Health2-0-0-2-
    PH703Advanced Pharmacovigilance2-0-0-2PH608
    PH704Regulatory Affairs in Biotechnology2-0-0-2-
    PH705Regulatory Affairs for Medical Devices2-0-0-2-
    PH706Pharmaceutical Patent Law2-0-0-2-
    PH707Regulatory Affairs for Combination Products2-0-0-2-
    PH708Regulatory Affairs for Biosimilars2-0-0-2-
    PH709Regulatory Affairs in Global Health Policy2-0-0-2-
    PH710Regulatory Affairs for Rare Diseases2-0-0-2-
    PH711Regulatory Affairs in Pharmacogenomics2-0-0-2-
    PH712Regulatory Affairs for Digital Therapeutics2-0-0-2-
    PH713Regulatory Affairs Capstone Project II0-0-6-2PH612
    PH714Mini Project III0-0-6-2PH613
    PH715Thesis Proposal0-0-6-2-
    Semester VIIIPH801Regulatory Affairs VI2-0-0-2PH701
    PH802Advanced Topics in Regulatory Affairs2-0-0-2-
    PH803Regulatory Affairs and Innovation2-0-0-2-
    PH804Regulatory Affairs for Global Supply Chains2-0-0-2-
    PH805Regulatory Affairs in Artificial Intelligence2-0-0-2-
    PH806Regulatory Affairs for Precision Medicine2-0-0-2-
    PH807Regulatory Affairs and Climate Change2-0-0-2-
    PH808Regulatory Affairs in Emerging Markets2-0-0-2-
    PH809Regulatory Affairs for Health Technology Assessment2-0-0-2-
    PH810Regulatory Affairs and Public Policy2-0-0-2-
    PH811Regulatory Affairs for Mental Health2-0-0-2-
    PH812Regulatory Affairs in Global Health Security2-0-0-2-
    PH813Thesis Writing and Presentation0-0-6-2PH715
    PH814Regulatory Affairs Thesis0-0-12-4PH813
    PH815Final Internship0-0-12-2-

    Detailed Course Descriptions for Advanced Departmental Electives

    The Drug Regulatory Affairs program at Ramanand Institute Of Pharmacy And Management Haridwar offers a range of advanced departmental elective courses designed to deepen students' understanding of specialized areas within regulatory affairs. These courses are taught by leading experts in their respective fields and provide insights into emerging trends, practical applications, and cutting-edge research.

    Biologics and Advanced Therapies Regulation

    This course explores the unique regulatory challenges associated with complex biological products such as vaccines, gene therapies, cell-based treatments, and recombinant proteins. Students will learn about specialized manufacturing requirements, quality control measures, safety monitoring protocols, and approval pathways for biologics in various global markets.

    Clinical Research Regulation

    Focused on the regulatory aspects of clinical research, this course covers topics such as investigational new drug (IND) applications, informed consent processes, data integrity requirements, and ethical considerations in clinical trials. Students will also study international guidelines for conducting clinical research and managing trial risks.

    Post-Market Surveillance Regulation

    This course focuses on monitoring drugs after they enter the market, covering adverse event reporting systems, risk management plans, pharmacovigilance strategies, and safety signal detection. Students will learn how to develop and implement surveillance programs that ensure continued safety and efficacy of approved products.

    Global Regulatory Strategy

    Designed for students interested in international drug regulation, this course covers regulatory harmonization efforts, cross-border compliance issues, and strategic planning required to launch drugs in multiple jurisdictions simultaneously. It includes case studies on successful global launches and regulatory challenges faced by multinational companies.

    Pharmaceutical Quality Assurance Regulation

    This course focuses on ensuring pharmaceutical products meet quality standards throughout their lifecycle, covering quality systems, batch release procedures, compliance with international quality guidelines, and risk-based approaches to quality management in regulated environments.

    Pediatric Drug Development Regulation

    Specializing in regulatory requirements for medicines intended for children, this course covers ethical considerations, dosing studies, special protocols required for pediatric formulations, and unique regulatory pathways for rare diseases. Students will also explore incentives provided by regulatory agencies to encourage pediatric drug development.

    Regulatory Affairs in Emerging Technologies

    This cutting-edge course explores the regulatory landscape for novel therapeutic approaches such as personalized medicine, digital therapeutics, artificial intelligence in drug development, and blockchain applications in pharmaceutical supply chains. Students will learn how emerging technologies impact traditional regulatory paradigms and how new frameworks are being developed to address these innovations.

    Regulatory Affairs for Orphan Drugs

    Focused on rare disease treatments, this course covers the regulatory incentives provided by various agencies for orphan drug development, including expedited approval pathways, market exclusivity periods, and financial support mechanisms. Students will also study challenges in conducting clinical trials for rare diseases and navigating regulatory requirements.

    Regulatory Affairs for Vaccine Development

    This course provides comprehensive coverage of vaccine regulatory processes, including preclinical development, clinical trial design, manufacturing standards, and approval pathways for vaccines. Students will explore the unique challenges of vaccine regulation, including safety monitoring, immunogenicity testing, and global harmonization efforts.

    Regulatory Affairs for Medical Devices

    Designed for students interested in medical device regulation, this course covers classification systems, premarket approval processes, post-market surveillance requirements, and quality management standards. Students will learn how regulatory frameworks differ between devices and drugs and gain practical experience in preparing device-related regulatory submissions.

    Project-Based Learning Philosophy

    The department's philosophy on project-based learning is rooted in the belief that real-world problem-solving skills are essential for success in the field of regulatory affairs. This approach emphasizes hands-on engagement with actual regulatory challenges, allowing students to apply theoretical knowledge in practical contexts.

    The structure of our project-based learning framework involves three major phases: mini-projects, capstone projects, and thesis research. Mini-projects are introduced in the third year and focus on specific regulatory topics such as preparing a regulatory submission for a hypothetical drug or conducting a risk assessment for a pharmaceutical product.

    Capstone projects in the final year involve extensive work on real-world regulatory challenges, often sponsored by industry partners. Students work closely with faculty mentors to develop comprehensive solutions that demonstrate their ability to navigate complex regulatory environments.

    The evaluation criteria for these projects emphasize critical thinking, analytical skills, regulatory knowledge application, and professional presentation abilities. Students are assessed not only on the technical quality of their work but also on their ability to communicate complex regulatory concepts effectively to both scientific and non-scientific audiences.

    Project selection is guided by student interests, faculty expertise, and current industry trends. Faculty mentors are assigned based on their area of specialization and relevance to the chosen project topic. This mentorship system ensures that students receive guidance from experts who can provide insights into both academic rigor and industry relevance.